Reading Time: 4 minutesThis is blog number 20 in our ‘Symposium Blogathon’ – counting down to the 32nd International Symposium on ALS/MND. Numbers in bold green type correspond
Tag: clinical trials
Reading Time: 5 minutesThis is blog number 19 in our ‘Symposium Blogathon’ – counting down to the 32nd International Symposium on ALS/MND. Numbers in bold green type correspond
Reading Time: 4 minutesThis is blog number 18 in our ‘Symposium Blogathon’ – counting down to the 32nd International Symposium on ALS/MND. Numbers in bold green type correspond
Reading Time: 4 minutesThis is blog number 17 in our ‘Symposium Blogathon’ – counting down to the 32nd International Symposium on ALS/MND. Numbers in bold green type correspond
Reading Time: 4 minutesThis is blog number 15 in our ‘Symposium Blogathon’ – counting down to the 32nd International Symposium on ALS/MND. Numbers in bold green type correspond
Reading Time: 7 minutesGlobal biotechnology company Biogen has announced plans to make tofersen, a potential treatment for people whose MND is believed to be driven by mutations in
Reading Time: 6 minutesEach year, MND Associations across the globe mark 21 June as a special day of recognition, acknowledging the impact that MND has on people around
Reading Time: 3 minutesThis is the first in a series of three blog articles from Session 7 – Perspectives: Lessons from COVID-19 in which we heard from different
Reading Time: 9 minutesA paper arising from research carried out at the University of Sheffield as part of the AMBRoSIA biobank, and in collaboration with the international Project